Kevin Warsh Confirmed as Federal Reserve Chair in Historically Narrow Senate Vote Gold Poised for Potential Gap Move as Technical Patterns Signal Volatile Weekly Open XTI Aerospace XTIA Reports Mixed Q1 2026 Revenue Beats but EPS Misses Michael Burry Warns of Market Excess as Top Stocks Surge 784 in a Year Echoing PreDotCom Era Regaal Resources Reports 24 Revenue Growth to 1134 Crore in Fiscal Year 2026 Lionsgate LION Surges to Record High Following Strong Earnings Report Gold Correction Nearing Completion Amid Shifting Market Sentiment Movado Group Files Quarterly 10Q Report Investors Scrutinize Financial Trends Flipkart Sets Record with 200 Million SingleDay Sales Highest Since 2007 Suzlon Energy Q4 2026 Results Profit Dips 6 YoY on Higher Costs Revenue Surges 45 WATT Q1 2026 Earnings EPS Surprise of 3464 Despite No Revenue Stock Declines CRWS Q1 2026 Earnings Modest EPS of 014 Reported Stock Edges Higher Allied Gaming Entertainment Inc AGAE Q1 2025 Earnings Narrowing Loss Through Strategic Restructuring Willdan Group WLDN Q1 2026 Earnings Earnings Beat Drives Share Price Higher MED Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction GSK Q1 2026 Earnings EPS Beats Estimates Amid Revenue Data Gap PROCEPT BioRobotics PRCT Rises on Positive Momentum Testing Key Resistance at 2847 Aemetis Inc AMTX Slides 67 as Renewable Energy Sector Faces Headwinds BGSF Inc BGSF Rallies 15 as Staffing Stock Breaks Above Support Zone CarPartscom PRTS Edges Higher as Stock Consolidates Near Key Support Playtika Holding Corp PLTK Faces Headwinds as Shares Decline Near Key Support NMIH Q1 2026 Earnings EPS Beats Estimates Shares Edge Lower Hub Group Q3 2025 Earnings EPS Falls Short of Estimates Stock Declines NCTY Q1 2012 Earnings Narrower Loss Beats Estimates as Company Restructures EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge TLN Q1 2026 Earnings EPS Falls Far Short of Estimates Yet Shares Edge Higher AI May Accelerate Discovery of Drugs for Brain Conditions Like MND QRHC Q1 2026 Earnings EPS Misses Estimates by 27 as Stock Edges Up Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance